Show simple item record

Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus

dc.contributor.authorSanchez, Elenaen_US
dc.contributor.authorWebb, Ryan D.en_US
dc.contributor.authorRasmussen, Astriden_US
dc.contributor.authorKelly, Jennifer A.en_US
dc.contributor.authorRiba, Lauraen_US
dc.contributor.authorKaufman, Kenneth M.en_US
dc.contributor.authorGarcia-de la Torre, Ignacioen_US
dc.contributor.authorMoctezuma, Jose F.en_US
dc.contributor.authorMaradiaga-Ceceña, Marco A.en_US
dc.contributor.authorCardiel-Rios, Mario H.en_US
dc.contributor.authorAcevedo, Eduardoen_US
dc.contributor.authorCucho-Venegas, Marianoen_US
dc.contributor.authorGarcia, Mercedes A.en_US
dc.contributor.authorGamron, Susanaen_US
dc.contributor.authorPons-Estel, Bernardo A.en_US
dc.contributor.authorVasconcelos, Carlosen_US
dc.contributor.authorMartin, Javieren_US
dc.contributor.authorTusié-Luna, Teresaen_US
dc.contributor.authorHarley, John B.en_US
dc.contributor.authorRichardson, Bruce C.en_US
dc.contributor.authorSawalha, Amr H.en_US
dc.contributor.authorAlarcón-Riquelme, Marta E.en_US
dc.date.accessioned2011-01-04T16:22:33Z
dc.date.available2011-03-01T16:26:42Zen_US
dc.date.issued2010-12en_US
dc.identifier.citationSanchez, Elena; Webb, Ryan D.; Rasmussen, Astrid; Kelly, Jennifer A.; Riba, Laura; Kaufman, Kenneth M.; Garcia-de la Torre, Ignacio; Moctezuma, Jose F.; Maradiaga-CeceÑa, Marco A.; Cardiel-Rios, Mario H.; Acevedo, Eduardo; Cucho-Venegas, Mariano; Garcia, Mercedes A.; Gamron, Susana; Pons-Estel, Bernardo A.; Vasconcelos, Carlos; Martin, Javier; TusiÉ-Luna, Teresa; Harley, John B.; Richardson, Bruce; Sawalha, Amr H.; AlarcÓn-Riquelme, Marta E. (2010). "Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus." Arthritis & Rheumatism 62(12): 3722-3729. <http://hdl.handle.net/2027.42/78480>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/78480
dc.description.abstractObjective To assess whether genetically determined Amerindian ancestry predicts increased presence of risk alleles of known susceptibility genes for systemic lupus erythematosus (SLE). Methods Single-nucleotide polymorphisms (SNPs) within 16 confirmed genetic susceptibility loci for SLE were genotyped in a set of 804 Mestizo lupus patients and 667 Mestizo healthy controls. In addition, 347 admixture informative markers were genotyped. Individual ancestry proportions were determined using STRUCTURE. Association analysis was performed using PLINK, and correlation between ancestry and the presence of risk alleles was analyzed using linear regression. Results A meta-analysis of the genetic association of the 16 SNPs across populations showed that TNFSF4 , STAT4 , ITGAM , and IRF5 were associated with lupus in a Hispanic Mestizo cohort enriched for European and Amerindian ancestry. In addition, 2 SNPs within the major histocompatibility complex region, previously shown to be associated in a genome-wide association study in Europeans, were also associated in Mestizos. Using linear regression, we predicted an average increase of 2.34 risk alleles when comparing an SLE patient with 100% Amerindian ancestry versus an SLE patient with 0% Amerindian ancestry ( P < 0.0001). SLE patients with 43% more Amerindian ancestry were predicted to carry 1 additional risk allele. Conclusion Our results demonstrate that Amerindian ancestry is associated with an increased number of risk alleles for SLE.en_US
dc.format.extent216889 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.titleGenetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosusen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan and VAMC, Ann Arboren_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, Oklahoma Cityen_US
dc.contributor.affiliationotherUniversity of Oklahoma Health Sciences Center, Oklahoma Cityen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, Oklahoma Cityen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, Oklahoma Cityen_US
dc.contributor.affiliationotherInstituto de Investigaciones BiomÉdicas de la Universidad Nacional AutÓnoma de MÉxico, and Instituto Nacional de Ciencias MÉdicas y NutriciÓn Salvador ZubirÁn, Mexico City, Mexicoen_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and VAMC, Oklahoma Cityen_US
dc.contributor.affiliationotherHospital General de Occidente, Zapopan, Mexicoen_US
dc.contributor.affiliationotherHospital General de MÉxico, Mexico City, Mexicoen_US
dc.contributor.affiliationotherHospital General de CuliacÁn, Culiacan, Mexicoen_US
dc.contributor.affiliationotherHospital General Dr. Miguel Silva, Morelia, Mexicoen_US
dc.contributor.affiliationotherHospital Nacional Guillermo Almenara Irigoyen, Lima, Peruen_US
dc.contributor.affiliationotherHospital Nacional Guillermo Almenara Irigoyen, Lima, Peruen_US
dc.contributor.affiliationotherHospital Interzonal General de Agudos “General San MartÍn,” La Plata, Argentinaen_US
dc.contributor.affiliationotherHospital Nacional de ClÍnicas, Universidad Nacional de CÓrdoba, Cordoba, Argentinaen_US
dc.contributor.affiliationotherSanatorio Parque, Rosario, Argentinaen_US
dc.contributor.affiliationotherHospital Santo Antonio, Unidade Multidisciplinar em InvestigaÇÃo BiomÉdica/Instituto de CiÊncias BiomÉdicas de Abel Salazar, Porto, Portugal ; Dr. Vasconcelos has received consulting fees, speaking fees, and/or honoraria from Merck, Sharp, and Dohme and Roche (less than $10,000 each).en_US
dc.contributor.affiliationotherInstituto de Biomedicina y ParasitologÍa LÓpez-Neyra, Consejo Superior de Investigaciones CientÍficas, Granada, Spainen_US
dc.contributor.affiliationotherInstituto de Investigaciones BiomÉdicas de la Universidad Nacional AutÓnoma de MÉxico, and Instituto Nacional de Ciencias MÉdicas y NutriciÓn Salvador ZubirÁn, Mexico City, Mexicoen_US
dc.contributor.affiliationotherCincinnati Children's Hospital Medical Center, Cincinnati, Ohio ; Dr. Harley has received consulting fees, speaking fees, and/or honoraria from Biorad Labs, Immunovision, and IVAX Diagnostics (more than $10,000 each) and owns stock in IVAX Diagnostics.en_US
dc.contributor.affiliationotherOklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, and VAMC, Oklahoma City ; Drs. Sawalha and AlarcÓn-Riquelme contributed equally to this work.en_US
dc.contributor.affiliationotherPfizer–Universidad de Granada–Junta de AndalucÍa, Granada, Spain and Oklahoma Medical Research Foundation, Oklahoma City ; Oklahoma Medical Research Foundation, 825 NE 13th Street, MS #24, Oklahoma City, OK 73104en_US
dc.identifier.pmid20848568en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/78480/1/27753_ftp.pdf
dc.identifier.doi10.1002/art.27753en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.